Related Experiment Video
Updated: Aug 17, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Using ibutilide to convert atrial fibrillation and flutter
1dsarg4525@aol.com
Abstract:
Ibutilide fumarate injection is the first antiarrhythmic drug approved by the Food and Drug Administration for acute conversion of atrial fibrillation and flutter of recent onset (up to 90 days). This drug will find its greatest use in critical care units and emergency departments. Critical care nurses monitor the patients, recognize and assist in treating adverse events, and evaluate patient outcomes. Advanced practice nurses will find this information useful for teaching patients, colleagues, and new critical care nurses.
Related Concept Videos
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias VI: Management of Dysrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

